Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids

Immunobiology

Volumn 213, Issue 3-4, 2008, Pages 329-340

  Schröder, Nicolas W J ^a   Eckert, Jana ^a   Stübs, Gunthard ^a   Schumann, Ralf R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Glycolipids; Innate immunity; Lipoproteins; Spirochetes; Toll like receptors

Indexed keywords

ACYLATED CHOLESTERYL GALACTOSIDE; ALPHA MONOGALACTOSYL DIACYLGLYCEROL; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CHOLESTEROL DERIVATIVE; DIACYLGLYCEROL DERIVATIVE; GLYCOLIPID; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; BACTERIAL OUTER MEMBRANE; BORRELIA; CELL ACTIVATION; CHEMICAL STRUCTURE; CYTOKINE RELEASE; DISEASE PREDISPOSITION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEPTOSPIRA; LYME DISEASE; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NATURAL KILLER T CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROCHETE INFECTION; TREPONEMA; VACCINE PRODUCTION;

EID: 41649095188     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.11.003     Document Type: Review

References (90)

1. Adler B., and Faine S. Evidence that leptospiral lipopolysaccharide is not an important protective antigen. J. Med. Microbiol. 15 (1982) 259-262
2. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
3. Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R.T., Medzhitov R., Fikrig E., and Flavell R.A. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8 (2002) 878-884
4. Asai Y., Hashimoto M., and Ogawa T. Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions. Eur. J. Immunol. 33 (2003) 3196-3204
5. Asai Y., Jinno T., and Ogawa T. Oral treponemes and their outer membrane extracts activate human gingival epithelial cells through toll-like receptor 2. Infect. Immun. 71 (2003) 717-725
6. Asai Y., Ohyama Y., Taiji Y., Makimura Y., Tamai R., Hashimoto M., and Ogawa T. Treponema medium glycoconjugate inhibits activation of human gingival fibroblasts stimulated with phenol-water extracts of periodontopathic bacteria. J. Dent. Res. 84 (2005) 456-461
7. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., and Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98 (2001) 9237-9242
8. Ben-Menachem G., Kubler-Kielb J., Coxon B., Yergey A., and Schneerson R. A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 100 (2003) 7913-7918
9. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., and Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24 (2006) 353-389
10. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., Akira S., and Ulmer A.J. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35 (2005) 282-289
11. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., Akira S., and Ulmer A.J. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 281 (2006) 9049-9057
12. Dahle U.R., Tronstad L., and Olsen I. 3-Hydroxy fatty acids in a lipopolysaccharide-like material from Treponema denticola strain FM. Endod. Dent. Traumatol. 12 (1996) 202-205
13. Dentener M.A., Vreugdenhil A.C., Hoet P.H., Vernooy J.H., Nieman F.H., Heumann D., Janssen Y.M., Buurman W.A., and Wouters E.F. Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am. J. Respir. Cell Mol. Biol. 23 (2000) 146-153
14. Fraser C.M., Casjens S., Huang W.M., Sutton G.G., Clayton R., Lathigra R., White O., Ketchum K.A., Dodson R., Hickey E.K., Gwinn M., Dougherty B., Tomb J.F., Fleischmann R.D., Richardson D., Peterson J., Kerlavage A.R., Quackenbush J., Salzberg S., Hanson M., van Vugt R., Palmer N., Adams M.D., Gocayne J., Weidman J., Utterback T., Watthey L., McDonald L., Artiach P., Bowman C., Garland S., Fuji C., Cotton M.D., Horst K., Roberts K., Hatch B., Smith H.O., and Venter J.C. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390 (1997) 580-586
15. Fraser C.M., Norris S.J., Weinstock G.M., White O., Sutton G.G., Dodson R., Gwinn M., Hickey E.K., Clayton R., Ketchum K.A., Sodergren E., Hardham J.M., McLeod M.P., Salzberg S., Peterson J., Khalak H., Richardson D., Howell J.K., Chidambaram M., Utterback T., McDonald L., Artiach P., Bowman C., Cotton M.D., Fujii C., Garland S., Hatch B., Horst K., Roberts K., Sandusky M., Weidman J., Smith H.O., and Venter J.C. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281 (1998) 375-388
16. Golden M.R., Marra C.M., and Holmes K.K. Update on syphilis: resurgence of an old problem. JAMA 290 (2003) 1510-1514
17. Godfrey D.I., Pellicci D.G., and Smyth M.J. The elusive NKT cell antigen - is the search over?. Science 306 (2004) 1687-1689
18. Habicht G.S., Beck G., Benach J.L., and Coleman J.L. Borrelia burgdorferi lipopolysaccharide and its role in the pathogenesis of Lyme disease. Zentralbl. Bakteriol. Mikrobiol. Hyg. [A] 263 (1986) 137-141
19. Hamann L., Gomma A., Schröder N.W., Stamme C., Glaeser C., Schulz S., Gross M., Anker S.D., Fox K., and Schumann R.R. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J. Mol. Med. 83 (2005) 478-485
20. Hashimoto M., Asai Y., and Ogawa T. Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 278 (2003) 44205-44213
21. Hengge U.R., Tannapfel A., Tyring S.K., Erbel R., Arendt G., and Ruzicka T. Lyme borreliosis. Lancet Infect. Dis. 3 (2003) 489-500
22. Hirschfeld M., Kirschning C.J., Schwandner R., Wesche H., Weis J.H., Wooten R.M., and Weis J.J. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 163 (1999) 2382-2386
23. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., Qureshi N., Michalek S.M., and Vogel S.N. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69 (2001) 1477-1482
24. Honarvar N., Schaible U.E., Galanos C., Wallich R., and Simon M.M. A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology 82 (1994) 389-396
25. Hossain H., Wellensiek H.J., Geyer R., and Lochnit G. Structural analysis of glycolipids from Borrelia burgdorferi. Biochimie 83 (2001) 683-692
26. Jackson S.W., and Zey P.N. Ultrastructure of lipopolysaccharide isolated from Treponema pallidum. J. Bacteriol. 114 (1973) 838-844
27. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., and Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130 (2007) 1071-1082
28. Johnson R.C. The spirochetes. Annu. Rev. Microbiol. 31 (1977) 89-106
29. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., Hamann L., Schumann R.R., and Tapping R.I. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178 (2007) 7520-7524
30. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., Zajonc D.M., Ben-Menachem G., Ainge G.D., Painter G.F., Khurana A., Hoebe K., Behar S.M., Beutler B., Wilson I.A., Tsuji M., Sellati T.J., Wong C.H., and Kronenberg M. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7 (2006) 978-986
31. Kirschning C.J., and Schumann R.R. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr. Top. Microbiol. Immunol. 270 (2002) 121-144
32. Lamping N., Dettmer R., Schröder N.W., Pfeil D., Hallatschek W., Burger R., and Schumann R.R. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J. Clin. Invest. 101 (1998) 2065-2071
33. Lee S.H., Kim K.K., Rhyu I.C., Koh S., Lee D.S., and Choi B.K. Phenol/water extract of Treponema socranskii subsp. socranskii as an antagonist of Toll-like receptor 4 signalling. Microbiology 152 (2006) 535-546
34. Lien E., Sellati T.J., Yoshimura A., Flo T.H., Rawadi G., Finberg R.W., Carroll J.D., Espevik T., Ingalls R.R., Radolf J.D., and Golenbock D.T. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274 (1999) 33419-33425
35. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., and Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105 (2000) 497-504
36. Livermore B.P., Bey R.F., and Johnson R.C. Lipid metabolism of Borrelia hermsi. Infect. Immun. 20 (1978) 215-220
37. Ma Y., and Weis J.J. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61 (1993) 3843-3853
38. Manukyan M., Triantafilou K., Triantafilou M., Mackie A., Nilsen N., Espevik T., Wiesmuller K.H., Ulmer A.J., and Heine H. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 35 (2005) 911-921
39. Mockenhaupt F.P., Cramer J.P., Hamann L., Stegemann M.S., Eckert J., Oh N.R., Otchwemah R.N., Dietz E., Ehrhardt S., Schröder N.W.J., Bienzle U., and Schumann R.R. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J. Commun. Dis. 38 (2006) 230-245
40. Morath S., Geyer A., and Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193 (2001) 393-397
41. Moter A., Hoenig C., Choi B.K., Riep B., and Göbel U.B. Molecular epidemiology of oral treponemes associated with periodontal disease. J. Clin. Microbiol. 36 (1998) 1399-1403
42. Nahori M.A., Fournie-Amazouz E., Que-Gewirth N.S., Balloy V., Chignard M., Raetz C.R., Saint Girons I., and Werts C. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J. Immunol. 175 (2005) 6022-6031
43. Norris S.J., and Weinstock G.M. The genome sequence of Treponema pallidum, the syphilis spirochete: will clinicians benefit?. Curr. Opin. Infect. Dis. 13 (2000) 29-36
44. Ogawa T., Asai Y., Makimura Y., and Tamai R. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front. Biosci. 12 (2007) 3795-3812
45. Omueti K.O., Beyer J.M., Johnson C.M., Lyle E.A., and Tapping R.I. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J. Biol. Chem. 280 (2005) 36616-36625
46. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7 (2007) 353-364
47. Opitz B., Schröder N.W.J., Spreitzer I., Michelsen K.S., Kirschning C.J., Hallatschek W., Zähringer U., Hartung T., Göbel U.B., and Schumann R.R. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J. Biol. Chem. 276 (2001) 22041-22047
48. Palaniappan R.U., Ramanujam S., and Chang Y.F. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr. Opin. Infect. Dis. 20 (2007) 284-292
49. Paster B.J., and Dewhirst F.E. Phylogenetic foundation of spirochetes. J. Mol. Microbiol. Biotechnol. 2 (2000) 341-344
50. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., and Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 12 (2006) 1-8
51. Pozsgay V., and Kubler-Kielb J. Synthesis of an experimental glycolipoprotein vaccine against Lyme disease. Carbohydr. Res. 342 (2007) 621-626
52. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., and Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167 (2001) 5067-5076
53. Que-Gewirth N.L., Ribeiro A.A., Kalb S.R., Cotter R.J., Bulach D.M., Adler B., Girons I.S., Werts C., and Raetz C.R. A methylated phosphate group and four amide-linked acyl chains in Leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J. Biol. Chem. 279 (2004) 25420-25429
54. Radolf J.D., Norgard M.V., Brandt M.E., Isaacs R.D., Thompson P.A., and Beutler B. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J. Immunol. 147 (1991) 1968-1974
55. Raetz C.R., and Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71 (2002) 635-700
56. Ren L., Jin L., and Leung W.K. Local expression of lipopolysaccharide-binding protein in human gingival tissues. J. Periodontal Res. 39 (2004) 242-248
57. Riviere G.R., Wagoner M.A., Baker-Zander S.A., Weisz K.S., Adams D.F., Simonson L., and Lukehart S.A. Identification of spirochetes related to Treponema pallidum in necrotizing ulcerative gingivitis and chronic periodontitis. N. Engl. J. Med. 325 (1991) 539-543
58. Schrank K., Choi B.K., Grund S., Moter A., Heuner K., Nattermann H., and Göbel U.B. Treponema brennaborense sp. nov., a novel spirochaete isolated from a dairy cow suffering from digital dermatitis. Int. J. Syst. Bacteriol. 49 Pt. 1 (1999) 43-50
59. Schröder, N.W.J., Schumann, R.R., 2005a. Pattern recognition. In: Kaufmann, S.H.E. (Ed.), Topley and Wilson's Microbiology and Microbial Infection-Immunology of Infectious Diseases. pp. 109 - 130.
60. Schröder N.W.J., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5 (2005) 156-164
61. Schröder N.W.J., Opitz B., Lamping N., Michelsen K.S., Zähringer U., Göbel U.B., and Schumann R.R. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J. Immunol. 165 (2000) 2683-2693
62. Schröder N.W.J., Pfeil D., Opitz B., Michelsen K.S., Amberger J., Zähringer U., Göbel U.B., and Schumann R.R. Activation of mitogen-activated protein kinases p42/44, p38, and stress-activated protein kinases in myelo-monocytic cells by Treponema lipoteichoic acid. J. Biol. Chem. 276 (2001) 9713-9719
63. Schröder N.W.J., Hermann C., Hamann L., Göbel U.B., Hartung T., and Schumann R.R. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 81 (2003) 368-372
64. Schröder N.W.J., Morath S., Alexander C., Hamann L., Hartung T., Zähringer U., Göbel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
65. Schröder N.W.J., Schombel U., Heine H., Göbel U.B., Zähringer U., and Schumann R.R. Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto. J. Biol. Chem. 278 (2003) 33645-33653
66. Schröder N.W.J., Heine H., Alexander C., Manukyan M., Eckert J., Hamann L., Göbel U.B., and Schumann R.R. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173 (2004) 2683-2691
67. Schröder N.W.J., Diterich I., Zinke A., Eckert J., Draing C., von Baehr V., Hassler D., Priem S., Hahn K., Michelsen K.S., Hartung T., Burmester G.R., Göbel U.B., Hermann C., and Schumann R.R. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175 (2005) 2534-2540
68. Schromm A.B., Howe J., Ulmer A.J., Wiesmuller K.H., Seyberth T., Jung G., Rossle M., Koch M.H., Gutsmann T., and Brandenburg K. Physicochemical and biological analysis of synthetic bacterial lipopeptides: validity of the concept of endotoxic conformation. J. Biol. Chem. 282 (2007) 11030-11037
69. Schultz C.P., Wolf V., Lange R., Mertens E., Wecke J., Naumann D., and Zahringer U. Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola. Functioning permeation barrier without lipopolysaccharides. J. Biol. Chem. 273 (1998) 15661-15666
70. Schumann R.R., and Tapping R.I. Genomic variants of TLR1 - it takes (TLR-)two to tango. Eur. J. Immunol. 37 (2007) 2059-2062
71. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., and Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 249 (1990) 1429-1431
72. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274 (1999) 17406-17409
73. Sela M.N., Bolotin A., Naor R., Weinberg A., and Rosen G. Lipoproteins of Treponema denticola: their effect on human polymorphonuclear neutrophils. J. Periodontal Res. 32 (1997) 455-466
74. Seshadri R., Myers G.S., Tettelin H., Eisen J.A., Heidelberg J.F., Dodson R.J., Davidsen T.M., DeBoy R.T., Fouts D.E., Haft D.H., Selengut J., Ren Q., Brinkac L.M., Madupu R., Kolonay J., Durkin S.A., Daugherty S.C., Shetty J., Shvartsbeyn A., Gebregeorgis E., Geer K., Tsegaye G., Malek J., Ayodeji B., Shatsman S., McLeod M.P., Smajs D., Howell J.K., Pal S., Amin A., Vashisth P., McNeill T.Z., Xiang Q., Sodergren E., Baca E., Weinstock G.M., Norris S.J., Fraser C.M., and Paulsen I.T. Comparison of the genome of the oral pathogen Treponema denticola with other spirochete genomes. Proc. Natl. Acad. Sci. USA 101 (2004) 5646-5651
75. Spiller S., Dreher S., Meng G., Grabiec A., Thomas W., Hartung T., Pfeffer K., Hochrein H., Brade H., Bessler W., Wagner H., and Kirschning C.J. Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J. Biol. Chem. 282 (2007) 13190-13198
76. Stanek G., and Strle F. Lyme borreliosis. Lancet 362 (2003) 1639-1647
77. Takayama K., Rothenberg R.J., and Barbour A.G. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55 (1987) 2311-2313
78. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., and Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13 (2001) 933-940
79. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., and Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169 (2002) 10-14
80. Tobias P.S., Soldau K., and Ulevitch R.J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164 (1986) 777-793
81. Vinh T., Adler B., and Faine S. Ultrastructure and chemical composition of lipopolysaccharide extracted from Leptospira interrogans serovar copenhageni. J. Gen. Microbiol. 132 (1986) 103-109
82. Vreugdenhil A.C., Dentener M.A., Snoek A.M., Greve J.W., and Buurman W.A. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J. Immunol. 163 (1999) 2792-2798
83. Walker S.G., Xu X., Altman E., Davis K.J., Ebersole J.L., and Holt S.C. Isolation and chemical analysis of a lipopolysaccharide from the outer membrane of the oral anaerobic spirochete Treponema pectinovorum. Oral Microbiol. Immunol. 14 (1999) 304-308
84. Weber J.R., Freyer D., Alexander C., Schröder N.W.J., Reiss A., Kuster C., Pfeil D., Tuomanen E.I., and Schumann R.R. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19 (2003) 269-279
85. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., Underhill D.M., Kirschning C.J., Wagner H., Aderem A., Tobias P.S., and Ulevitch R.J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2 (2001) 346-352
86. Wilske B., Fingerle V., and Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 49 (2007) 13-21
87. Wooten R.M., Modur V.R., McIntyre T.M., and Weis J.J. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J. Immunol. 157 (1996) 4584-4590
88. Wyss C., Choi B.K., Schupbach P., Guggenheim B., and Gobel U.B. Treponema maltophilum sp. nov., a small oral spirochete isolated from human periodontal lesions. Int. J. Syst. Bacteriol. 46 (1996) 745-752
89. Yotis W.W., Sharma V.K., Gopalsami C., Chegini S., McNulty J., Hoerman K., Keene Jr. J., and Simonson L.G. Biochemical properties of the outer membrane of Treponema denticola. J. Clin. Microbiol. 29 (1991) 1397-1406
90. Zweigner J., Gramm H.J., Singer O.C., Wegscheider K., and Schumann R.R. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98 (2001) 3800-3808